Factors Influencing Collection and Engraftment of CD34+Cells in Patients with Breast Cancer Following High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Cell Transplantation

2000 ◽  
Vol 9 (1) ◽  
pp. 103-109 ◽  
Author(s):  
Miguel A. Canales ◽  
Rosario Arrieta ◽  
M. Carmen Hernandez-Garcia ◽  
Emilio Ojeda ◽  
Jesus Diez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cell Transplantation ◽  
Peripheral Blood ◽  
Progenitor Cell ◽  
High Dose Chemotherapy ◽  
Peripheral Blood Progenitor Cell ◽  
High Dose ◽  
Factors Influencing ◽  
Cd34 Cells

Role of Parenteral Nutrition in Cancer Patients Undergoing High-Dose Chemotherapy Followed by Autologous Peripheral Blood Progenitor Cell Transplantation

2005 ◽  
Vol 91 (3) ◽  
pp. 237-240 ◽  
Author(s):  
Alfredo Tartarone ◽  
Jenna Wunder ◽  
Gianpiero Romano ◽  
Raffaele Ardito ◽  
Giovanni lodice ◽  
...  
Keyword(s):  
Parenteral Nutrition ◽  
Cell Transplantation ◽  
Peripheral Blood ◽  
Progenitor Cell ◽  
Autologous Bone Marrow ◽  
High Dose Chemotherapy ◽  
Peripheral Blood Progenitor Cell ◽  
High Dose ◽  
Conditioning Regimens

High-dose chemotherapy followed by autologous bone marrow or peripheral blood progenitor cell transplantation represents a recognized option in the treatment of solid tumors and hematologic diseases. Patients receiving high-dose chemotherapy are traditionally supported with parenteral nutrition with the aim to prevent malnutrition secondary to gastrointestinal toxicity and metabolic alterations induced by the conditioning regimens. Nevertheless, well-defined guidelines for its use in this clinical setting are lacking and there are several areas of controversy.

Sign in / Sign up

Export Citation Format

Share Document